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Abstract—An in vivo investigation of synthetic aperture flow
imaging using a dual stage beamformer is presented in this
paper. In the previous work, simulations and Doppler flow
phantom experiments showed promising results, which indicated
the methods capability of producing fast color flow mapping with
a good quality. Due to the continuous data, both high velocity and
low velocity can be estimated. Moreover, synthetic aperture flow
imaging can be implemented on a commercial platform, because
the number of calculations have been reduced. In this work,
A commercial ultrasound scanner (Pro Focus equipped with a
UA 2227 Research Interface, BK Medical, Herlev, Denmark)
was used to transmit signals and record echoes. The data are
processed off-line. The method is validated using a pulsatile flow
phantom. Volume flow is calculated, and is compared with the
volume flow set for the pump. The relative standard deviation is
14.3% and relative bias is 6.4% for the phantom measurements.
The blood flow in a common carotid artery of a 35-year-old
healthy male is scanned by a medical doctor (PMH). The in vivo
data is processed off-line. Fast synthetic aperture color flow
mapping with frame rate of 85 Hz is produced and the volume
flow is calculated.
I. INTRODUCTION
Synthetic aperture sequential beamforming (SASB) has
been investigated by Kortbek and Jensen [1] through simula-
tions and phantom measurements. Hemmsen et al [2] extended
SASB to convex array transducer and studied its performance
on in vivo data. These demonstrates that SASB can produce
ultrasound images with good penetration, lateral resolution
independency, and less calculations are required compared to
full synthetic aperture imaging. In our previous work [3], [4],
synthetic aperture using a dual stage beamformer approach
is used for flow imaging. Simulations and flow phantom
experiments showed that the new method can produce fast
color flow images for constant flow. The standard deviations
and the bias are less than 10%, if parameters are optimized.
The purpose of the research presented in this paper is to
validate the dual beamformer approach approach on in vivo
data. A commercial ultrasound scanner was used to produce
data, which are focused using a fixed delay profile along
the depth. Before the in vivo measurements, the method is
validated using a pulsatile flow phantom mimicking blood
flow over the cardiac cycle. Several important parameters are
explained and discussed. The volume flow is calculated and
compared with the waveform generated by the flow pump. The
optimized setup is used for in vivo data processing. The blood
flow in a common carotid artery is scanned, and the recorded
signals are processed off-line.
II. METHOD AND DATA ACQUISITION SYSTEM
A focused ultrasound beam is transmitted by a sub-aperture,
and echoes are received by the same aperture. Focusing is
split into two steps. Data are only focused at virtual source
in the first stage, and are focused dynamically in the second
stage. The high resolution image is created by adding a number
of newest low resolution images. The complete experimental
setup consists of two units: the ultrasound research system
and the flow circulation system. The flow circulation system
consists of a blood-mimicking fluid and a PC-controlled pump
(CompuFlow 1000, Shelley Medical Imaging Technologies,
London, Ontario, Canada) [5]. The ultrasound research sys-
tem [6] consists of a commercial ultrasound scanner (Pro Fo-
cus equipped with a UA 2227 Research Interface, BK Medical,
Herlev, Denmark) and a standard PC. The beamformed signals
with a fixed virtual source is recorded, and are processed off-
line to make a color flow image.
The basic parameters used in the experiment are shown in
Table I
TABLE I
PARAMETERS FOR THE MEASUREMENT.
Parameter Value Unit
Central frequency 7 MHz
Sampling frequency 34.28576 MHz
Total elements 192
Transducer pitch 0.208 mm
Transducer height 4.5 mm
Transmit and receive focal depth (virtual source) 5 mm
F number in transmit 0.5
F number in receive 2
Radius of vessel 6.4 mm
III. OPTIMIZATION OF PARAMETERS
To make a proper in vivo scanning, the estimation scheme
should be reexamined and optimized. In this section, several
important parameters are discussed. The optimization is made
based on pulsatile flow phantom measurement, and the results
are discussed as well.
1) Number of transmissions
The velocities are found by cross-correlating two images from
the same transmission sequence. The true pulse repetition time
used in the velocity estimator is dependent on the time period
between the two emissions
T ′prf = N · Tprf , (1)
where N is the number of emissions in one sequence and Tprf
is the time period between two consecutive emissions.
On the other hand, the number of transmissions determine
the image area. More emissions with large sparseness can
generate larger images, because the apodization function
applied on the LRIs, the image area at a given depth is
determined by the number of emissions used for constructing
a HRI. Therefore, the number of transmissions is limited to
N = 4, which balances the motion effects against the width
of the images.
2) The position of virtual sources
Two points have to be considered when deciding the position
of virtual sources: a) Opening angle: The relation between the
opening angle α and F# is α = 2 arctan 1
2F#
. The virtual
source at small depths yields a large opening angle, i.e. a
large spatial span. Such setup can expand the imaging area.
b) Position: Because the transmit beam is only focused at the
virtual source and sparse transmission sequence is employed,
the signal-to-noise ratio in the area between two consecutive
virtual sources is very low. Thus, choosing its position as the
same as the target should be avoided.
To make in vivo measurements possible, a ’blind area’
between virtual sources should be carefully considered. For
example, the carotid artery is the scanning target for the in
vivo measurement. Normally, in the upper part of its course it
is more superficial, being covered merely by the integument,
the superficial fascia. The distance between the common
carotid artery and superficial integument is very short (only
18-20 mm in the volunteer’s neck). Therefore, it is not
suitable to set the virtual source at that depth. To prevent
placing the common carotid artery in the ’blind area’, the
virtual sources are set at 5 mm from the transducer.
3) Number of averaged cross-correlation functions
A number of cross-correlation functions are averaged to im-
prove the performance of cross-correlation function. The pro-
cedure is predicted on the assumption that the cross-correlation
functions have the same position of the maximum peak, i.e.
the time shift remains the same over the averaging time. For
a constant flow, any number of estimates can be averaged,
since the velocities does not change over time. However, this
will not be the case for pulsatile flow, because the velocity is
a function of both time and position. There are accelerations
and decelerations of blood flow in the human vessel, thus a
gradual shift in the position of the peak will occur due to
changing velocity. The gradual shift should be limited to no
more than half a sample over the entire time duration of the
averaging. A velocity change corresponding to half a sample
shift (∆z) is
∆ν 1
2
=
1
2∆z
NTprf
. (2)
It should be less than the velocity change within the averaging
period. The velocity change in the blood vessel is defined as
a·Tavg = a·Nc·Tprf , where a is the acceleration of the blood
flow
a =
peak velocity − low velocity
pulse rise time
. (3)
Fig. 1 illustrates how the values are measured from a velocity
waveform. After reading values from the figure, the accelera-
tion of the flow is approximately 2.4 m/s2 in the carotid artery.
The relation requires that
a·Nc·Tprf <
1
2∆z
NTprf
. (4)
For the current imaging situation, the parameters are N = 4,
fs = 34.29 MHz, c = 1540 m/s, fprf = 11 kHz. It yields a
maximum averaging time of Tavg≈13 ms, which corresponds
to Nc = 142.
Peak velocity
Low velocity
Pulse rise time
Fig. 1. Illustration of a flow waveform in a common carotid artery. The
pulse rise time is defined as the period from the onset to the peak velocity.
In this time period, the rate of velocity change is largest. (To average cross-
correlation functions that have the same maximum peak, the velocity change
over the averaging time should be less than that of half a sample shift.)
4) Echo canceling
In ultrasound flow measurements, the blood signals are cor-
rupted with clutter signals from muscular tissue, vessel walls
etc, which are much stronger than the blood signals [8]. The
purpose of echo canceling is to remove the strong echo signals
from the stationary or slowly moving tissues. If the stationary
signals are not suppressed, they are strong enough to mask
the weak echoes from blood, making it impossible to estimate
velocities from them.
In this work, a simple mean subtraction algorithm is
used to remove the stationary signals. The mean value of
the slow-time signal is subtracted from each sample in the
signal. The images input to the echo canceler are from the
same emission sequence, i.e. from n + k·N , where k is an
integer. Images from different sequence can give rise to more
decorrelations and the operations on them can introduce
errors. In the in vivo measurements, the echo canceling is
applied after the beamformation and 16∼32 HRIs are chosen
to calculate the mean value. Willemetz et al [9] reported that
delay-line cancellers lead to biased estimates of frequency
at low signal-to-noise ratios, however other more advanced
approaches have been investigated [10], [11]. Since the HRIs
are continuously available, no initialization of the filter is
necessary, which can make echo canceling very efficient.
5) Intensity measurements
To make in vivo measurements, the derated global maximum
acoustic output has to be measured, and should not exceed
FDA acoustic output exposure levels (see Table II) [12].
Spatial-peak temporal-average intensity Ispta, spatial-peak
pulse-average intensity Isppa, and mechanical index have all
been measured. All measurements are derated by an attenua-
tion of 0.3 dB/cm-MHz.
The acoustic outputs were measured in a water tank using a
high precision acoustic intensity measurement system (AIMS
III with Soniq 5.0 software) and a HGL0400 hydrophone
(Onda, Sunnyvale, CA, USA). Table II shows that the trans-
mission used invivo are within the FDA limits.
TABLE II
PREAMENDMENTS ACOUSTIC OUTPUT EXPOSURE
Use ISPTA.3(mW/cm2) ISPPA.3(W/cm2) MI
Peripheral vessel 720 190 1.9
Actual value 609 145 0.94
IV. PULSATILE PHANTOM MEASUREMENTS
The flow phantom generates a pulsatile waveform mimick-
ing the blood flow in a common carotid artery. A commercial
scanner is used for transmit and receive ultrasound signals. The
recorded echoes are processed off-line. The estimated volume
flow is compared to the flow produced by the flow pump. The
instantaneous flow is defined as
Q = pi
K∑
n=1
rn∆rνn, (5)
where rn is the distance of the semi-annulus from the centroid,
∆r is the size of the uniformly spaced sample volumes, and
νn is the angle corrected velocity in a segment. The result is
shown in Fig. 2, where the estimated volume flow is compared
with the actual volume flow produced by the flow pump. The
standard deviation is 1.43 ml/s, and the mean bias is 0.64 ml/s
corresponding to a relative standard deviation of 14.3% and a
mean relative bias of 6.4% comparing with the peak volume
flow of 10 ml/s in the pulsatile period.
The main difference is the shift of the curve in the systolic
period. Since the reference waveform is the ideal output of
the flow pump, the actual measurement is also dependent on
the geometry of the vessel. The flow phantom used in the
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Fig. 2. The estimated volume flow for the flow circulation experiment
compared with the expected flow profile produced by the flow pump. The
complete time period of the pulsatile flow in the carotid artery is 774 ms.
Fig. 3. Color flow mapping of the flow circulation experiment. The flow-
to-beam angle is 79 degrees measured from the B-mode image. The image
is captured at 264 ms.
experiment contains a straight tube connecting to a bifurcating
tube, and the measurements are made at the place, which is
7.5 cm from the start of the bifurcation. It could be a factor
influencing the final flow profile and causing the difference.
Another concern for the shift is that all calculations are made
under a assumption of symmetrical flow profile. Errors can
occur if the flow exhibits skewing in the scan plane, i.e. when
the peak velocity is not in the geometric center of the vessel.
V. IN VIVO MEASUREMENTS
A common carotid artery of a healthy 35 year old male was
scanned by a medical doctor (PMH). The virtual source is set
to 5 mm and 2 cycle ultrasound pulses were emitted with a
center frequency of 7 MHz. The pulse repetion frequency is set
to 11 kHz, and approximately 2 seconds of data are acquired
corresponding to 22, 000 echo signals. The received signals
are convolved with a match filter, and then reconstructed in
a two-stage beamformer to form HRIs, and finally the cross-
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Fig. 4. The estimated volume flow for the in vivo measurement.
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Fig. 5. Volume flow for two cardiac cycles plotted on top of each other.
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Fig. 6. Color flow mapping of the flow circulation experiment. The flow-
to-beam angle is 73.4 degrees measured from the B-mode image. The left
image is captured at 230 ms, and the right is captured at 650 ms.
correlation technique is applied on these HRIs. Velocities are
found using 30 sequences corresponding to 120 LRIs, and
echo canceling is made by subtracting the mean value.
Fig. 4 illustrates the estimated volume flow as a function
of time. Fig. 5 shows that two consecutive cardiac cycles
are consistent over time. Fig. 6 show the in vivo color flow
mapping. The diameter of the blood vessel is approximately 6
mm depending on where in the cardiac cycle it is measured.
The geometry of the blood vessel is assumed as a cylinder
with a symmetric cross section. The maximum value is 26.3
ml/s. The curve indicates that the volume flow is positive at
all times during the scan, which is characteristic for the flow
in the common carotid artery.
VI. DISCUSSION AND CONCLUSION
The new method has been evaluated on a flow phantom,
which can generate pulsatile flow waveform. The volume
flow is calculated to quantify the performance. A relative
standard deviation of 14.3% and bias of 6.4% are achieved
using the optimized measurement setup. In the flow phantom
experiment, the method is further investigated to obtain a set
of reasonable measurement parameters. The new method has
been tested in vivo on the blood flow of the common carotid
artery of a healthy 35 years old male. Color flow mapping is
calculated for visualizing the blood in the vessel and volume
flow is calculated to see the cardiac cycles.
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